Biallelic start loss variant, c.1A > G in GCSH is associated with variant nonketotic hyperglycinemia

Clin Genet. 2021 Aug;100(2):201-205. doi: 10.1111/cge.13970. Epub 2021 May 3.

Abstract

The glycine cleavage system H protein (GCSH) is an integral part of the glycine cleavage system with its additional involvement in the synthesis and transport of lipoic acid. We hypothesize that pathogenic variants in GCSH can cause variant nonketotic hyperglycinemia (NKH), a heterogeneous group of disorders with findings resembling a combination of severe NKH (elevated levels of glycine in plasma and CSF, progressive lethargy, seizures, severe hypotonia, no developmental progress, early death) and mitochondriopathies (lactic acidosis, leukoencephalopathy and Leigh-like lesions on MRI). We herein report three individuals from two unrelated Indian families with clinical, biochemical, and radiological findings of variant NKH, harboring a biallelic start loss variant, c.1A > G in GCSH.

Keywords: GCSH; glycine cleavage system; lipoic acid; nonketotic hyperglycinemia; variant NKH.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Child, Preschool
  • Female
  • Glycine / blood
  • Glycine / cerebrospinal fluid
  • Glycine Decarboxylase Complex H-Protein / genetics*
  • Humans
  • Hyperglycinemia, Nonketotic / etiology
  • Hyperglycinemia, Nonketotic / genetics*
  • Male
  • Mutation
  • Pedigree

Substances

  • Glycine Decarboxylase Complex H-Protein
  • Glycine